RVP Key Statistics, Chart & Performance
The current stock price of RVP is 0.7713 USD. In the past month the price decreased by -5.65%. In the past year, price increased by 4.23%.
RVP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 20.21 | 16.59B | ||
| SOLV | SOLVENTUM CORP | 14.5 | 14.94B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.87 | 12.40B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.22 | 5.12B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.34 | 4.48B | ||
| HAE | HAEMONETICS CORP/MASS | 17.09 | 3.84B | ||
| ICUI | ICU MEDICAL INC | 19.22 | 3.78B | ||
| XRAY | DENTSPLY SIRONA INC | 8.09 | 2.55B | ||
| NEOG | NEOGEN CORP | 33.17 | 2.09B | ||
| UFPT | UFP TECHNOLOGIES INC | 29.84 | 1.99B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.10B | ||
| EMBC | EMBECTA CORP | 4.3 | 746.59M |
Related stock screener links
About RVP
Company Profile
Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. The company is headquartered in Little Elm, Texas and currently employs 221 full-time employees. The company went IPO on 2001-05-04. The firm is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Company Info
RETRACTABLE TECHNOLOGIES INC
511 Lobo Lane
Little Elm TEXAS 75068 US
CEO: Thomas J. Shaw
Employees: 221
Phone: 19722941010
RETRACTABLE TECHNOLOGIES INC / RVP FAQ
Can you describe the business of RETRACTABLE TECHNOLOGIES INC?
Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. The company is headquartered in Little Elm, Texas and currently employs 221 full-time employees. The company went IPO on 2001-05-04. The firm is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
What is the current price of RVP stock?
The current stock price of RVP is 0.7713 USD. The price decreased by -1.1% in the last trading session.
What is the dividend status of RETRACTABLE TECHNOLOGIES INC?
RVP does not pay a dividend.
How is the ChartMill rating for RETRACTABLE TECHNOLOGIES INC?
RVP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the next earnings date for RVP stock?
RETRACTABLE TECHNOLOGIES INC (RVP) will report earnings on 2026-03-26.
RVP Technical Analysis
RVP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RVP. While RVP seems to be doing ok healthwise, there are quite some concerns on its profitability.
RVP Financial Highlights
Over the last trailing twelve months RVP reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 58.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.56% | ||
| ROE | -8.7% | ||
| Debt/Equity | 0.01 |